Search results
Results From The WOW.Com Content Network
Purpose. test cognitive impairment. The Addenbrooke's Cognitive Examination (ACE) and its subsequent versions (Addenbrooke's Cognitive Examination-Revised, ACE-R [ 1] and Addenbrooke's Cognitive Examination III, ACE-III) are neuropsychological tests used to identify cognitive impairment in conditions such as dementia .
The onset of the deficits has been between the ages of 40 and 90 years and finally there must be an absence of other diseases capable of producing a dementia syndrome. Possible Alzheimer's disease : There is a dementia syndrome with an atypical onset, presentation or progression; and without a known etiology; but no co-morbid diseases capable ...
Research at King's College London explored the hazards of suboptimal prescribing and polypharmacy in medicines use for people with dementia. They determined that each year there are globally up to 10 million people living with dementia require hospital treatment (emergency department or hospital admissions) related to medicines related harm for ...
The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) is a questionnaire that can be filled out by a relative or other supporter of an older person to determine whether that person has declined in cognitive functioning. The IQCODE is used as a screening test for dementia. If the person is found to have significant cognitive ...
Stage 3: Mild cognitive impairment; people get lost or struggle to find words. Stage 4: Moderate dementia: limited short-term memory; people begin to forget their personal history. Stage 5 ...
Studies have found that wildfire smoke negatively affects brain health. New research suggests that increased exposure to smoke is associated with a higher risk of dementia. As wildfires become ...
“The APOE-e4 allele is the most important for Alzheimer’s disease risk,” she continued.“About 25% of people in the U.S. have at least one APOE-e4 allele and about 5% have two copies of it ...
ADAS-Cog. The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) is a brief neuropsychological assessment used to assess the severity of cognitive symptoms of dementia. It is one of the most widely used cognitive scales in clinical trials [ 1] and is considered to be the “gold standard” for assessing antidementia treatments.